Sangamo in Global Epigenetic Regulation and Capsid Delivery License Agreement With Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases >SGMO
Sangamo in Global Epigenetic Regulation and Capsid Delivery License Agreement With Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases >SGMO
Sangamo与Genentech签订全球表观遗传调控及帽蛋白传递授权协议，开发治疗神经退行性疾病的新型基因药物>SGMO
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册